Bruker Corporation (BRKR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bruker Corporation (BRKR:NASDAQ), powered by AI.

Current Price
$54.23
P/E Ratio
-957.2
Market Cap
8.2B
Sector
Healthcare
What is the Bruker Corporation stock price forecast?

Bruker Corporation is currently trading at $54.23. View real-time AI analysis on Alpha Lenz.

What is Bruker Corporation insider trading activity?

View the latest insider trading data for Bruker Corporation on Alpha Lenz.

What is Bruker Corporation's P/E ratio?

Bruker Corporation's P/E ratio is -957.2.

Bruker Corporation

NASDAQ · BRKR
$54.23-0.95(-1.72%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Bruker Corporation's future dividend policy...
Alpha Chat Insight

Bruker Corporation trades at a P/E of -957.2 (undervalued) with modest ROE of -0.4%. 3Y revenue CAGR of 10.7% highlights clear growth momentum.

Ask for details

Company Overview

Bruker Corporation is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The corporation focuses on providing cutting-edge technologies for a variety of industries, including life sciences, medical diagnostics, material and chemical analysis, as well as industrial applications. One of Bruker's primary functions is to enable scientists to explore and understand different materials at multiple levels, ranging from atomic to macroscopic scale. Specializing in technologies such as magnetic resonance, mass spectrometry, and X-ray systems, Bruker plays a crucial role in the advancement of scientific research and innovation. Its instruments are essential tools in the pharmaceutical industry for drug discovery and development, in environmental science for pollution monitoring, and in academic research for studying complex biological systems. With a global presence, Bruker Corporation is headquartered in Billerica, Massachusetts, and consistently influences the scientific community with its commitment to precision and innovation. As a component of the instruments and controls sector, Bruker contributes significantly to the broader technological advancements driving both industry progress and academic research.

CEODr. Frank H. Laukien Ph.D.
SectorHealthcare
IndustryMedical Devices
Employees11,396

Company Statistics

FY 2025

Profile

$8.23BMarket Cap
$3.44BRevenue
0.00Shares Out
11,396Employees

Margins

45.91%Gross
13.29%EBITDA
6.87%Operating
0.64%Pre-Tax
-0.24%Net

Valuation

-957.22P/E
3.35P/B
2.40EV/Sales
21.96EV/EBITDA
592.24P/FCF

Growth (CAGR)

10.74%Rev 3Yr
11.57%Rev 5Yr
-19.89%Op Inc 3Yr
-2.22%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-0.14%ROA
-0.41%ROE
1.37%ROIC

Financial Health

$298.80MCash & Cash Equivalents
$3.43BNet Debt
148.63%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bruker Corporation (ticker: BRKR) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 11,396 employees. Market cap is $8.2B.

The current price is $54.23 with a P/E ratio of -957.22x and P/B of 3.35x.

ROE is -0.41% and operating margin is 6.87%. Annual revenue is $3.4B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bruker Corporation (BRKR) Stock Forecast 2026 $54.23 — Price, Financials & Analyst Targets | Alpha Lenz